Siller, S., Lauseker, M., Giese, A., Tonn, J., Niyazi, K., Thon, N., . . . Kreth, F. (2019). PATH-04. INFLUENCE OF INDIVIDUAL CpG METHYLATION STATUS OF THE MGMT PROMOTOR ON OUTCOME IN ADULT PATIENTS WITH GLIOBLASTOMA MULTIFORME RECEIVING ALKYLATING AGENT TREATMENT. Neuro Oncol.
Citação norma ChicagoSiller, Sebastian, Michael Lauseker, Armin Giese, Joerg-Christian Tonn, Karim-Maximilian Niyazi, Niklas Thon, Bogdana Suchorska, and Friedrich-Wilhelm Kreth. "PATH-04. INFLUENCE OF INDIVIDUAL CpG METHYLATION STATUS OF THE MGMT PROMOTOR ON OUTCOME IN ADULT PATIENTS WITH GLIOBLASTOMA MULTIFORME RECEIVING ALKYLATING AGENT TREATMENT." Neuro Oncol 2019.
MLA CitationSiller, Sebastian, et al. "PATH-04. INFLUENCE OF INDIVIDUAL CpG METHYLATION STATUS OF THE MGMT PROMOTOR ON OUTCOME IN ADULT PATIENTS WITH GLIOBLASTOMA MULTIFORME RECEIVING ALKYLATING AGENT TREATMENT." Neuro Oncol 2019.